相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comparing the Benefit of Novel Therapies Across Clinical Trials Insights From the VICTORIA Trial
Javed Butler et al.
CIRCULATION (2020)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial
Paul W. Armstrong et al.
JACC-HEART FAILURE (2018)
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
Naoki Okumura et al.
CIRCULATION (2016)
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation The PARADIGM-HF Trial
Scott D. Solomon et al.
JACC-HEART FAILURE (2016)
Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction
Natalie A. Bello et al.
CIRCULATION-HEART FAILURE (2014)
Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
Hicham Skali et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)